Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use

The comparative outcomes of specific aminoglycosides in cavitary type (fibrocavitary or cavitary nodular bronchiectatic type) Mycobacterium avium complex (MAC) pulmonary disease (PD) are unelucidated. We investigated the treatment outcomes with streptomycin or amikacin inclusion in the treatment reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seong Min, Chong, Yong Pil, Lee, Hyun Joo, Shim, Tae Sun, Jo, Kyung-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269653/
https://www.ncbi.nlm.nih.gov/pubmed/37022189
http://dx.doi.org/10.1128/spectrum.04741-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269653/
https://www.ncbi.nlm.nih.gov/pubmed/37022189
http://dx.doi.org/10.1128/spectrum.04741-22

Ejemplares similares